Insider Transactions in Q1 2025 at Rigel Pharmaceuticals Inc (RIGL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Raymond J. Furey EVP, GC, CCO & Corp Sec |
SELL
Open market or private sale
|
Direct |
1,339
-3.33%
|
$28,119
$21.93 P/Share
|
|
Feb 05
2025
|
Raul R Rodriguez CEO, President |
SELL
Open market or private sale
|
Direct |
4,400
-1.8%
|
$92,400
$21.93 P/Share
|
|
Feb 05
2025
|
David A Santos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,796
-3.36%
|
$37,716
$21.93 P/Share
|
|
Feb 05
2025
|
Dean L Schorno EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,734
-2.94%
|
$36,414
$21.93 P/Share
|
|
Feb 04
2025
|
Raymond J. Furey EVP, GC, CCO & Corp Sec |
SELL
Open market or private sale
|
Direct |
1,448
-3.48%
|
$28,960
$20.92 P/Share
|
|
Feb 04
2025
|
Raul R Rodriguez CEO, President |
SELL
Open market or private sale
|
Direct |
4,952
-1.99%
|
$99,040
$20.92 P/Share
|
|
Feb 04
2025
|
David A Santos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,125
-3.82%
|
$42,500
$20.92 P/Share
|
|
Feb 04
2025
|
Dean L Schorno EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,036
-3.34%
|
$40,720
$20.92 P/Share
|
|
Jan 29
2025
|
Raymond J. Furey EVP, GC, CCO & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
19,717
+32.15%
|
-
|
|
Jan 29
2025
|
David A Santos EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,717
+26.17%
|
-
|
|
Jan 29
2025
|
Dean L Schorno EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,717
+24.43%
|
-
|
|
Jan 29
2025
|
Raul R Rodriguez CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
42,300
+14.53%
|
-
|
|
Jan 29
2025
|
Lisa Rojkjaer EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,717
+50.0%
|
-
|
|
Jan 24
2025
|
Raul R Rodriguez CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
88,156
-17.62%
|
$1,939,432
$22.17 P/Share
|
|
Jan 24
2025
|
Raul R Rodriguez CEO, President |
BUY
Exercise of conversion of derivative security
|
Direct |
90,000
+15.25%
|
$1,890,000
$21.4 P/Share
|